• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩散加权全身磁共振成像的表观扩散系数独立影响多发性骨髓瘤的生存期。

The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently.

作者信息

Zhang Bei, Bian Bingyang, Zhang Yanjiao, Zhang Li, Zhang Rongkui, Wang Jiping

机构信息

Department of Radiology, First Hospital of Jilin University, Changchun, China.

Department of Hematology, First Hospital of Jilin University, Changchun, China.

出版信息

Front Oncol. 2022 Mar 4;12:780078. doi: 10.3389/fonc.2022.780078. eCollection 2022.

DOI:10.3389/fonc.2022.780078
PMID:35311101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8931198/
Abstract

BACKGROUND

Diffusion-weighted whole-body MRI (DW-MRI) is increasingly used to evaluate bone diseases of multiple myeloma (MM), but there is lack of quantitative indicator for DW-MRI to reflect the prognosis of MM. Apparent diffusion coefficient (ADC) values in DW-MRI has potential correlations between some indexes of MM, but the influence of ADC on MM survival needs to be further verified.

METHODS

A total of 381 newly diagnosed MM patients were enrolled in the study to analyze the effect of ADC values in DW-MRI on progression-free survival (PFS) and overall survival (OS). The Kaplan-Meier method was used to perform univariate survival analysis, and the Cox proportional hazards model was used for multivariate analysis. In addition to the ADC value, genetic and serological indexes were also included.

RESULTS

The survivals were observed in univariate ADC stratification with median PFS of 52.0, 45.0, 34.0, and 26.0 months (the unit of ADC value was 10 mm/s; the ADC ranges were ADC < 0.4886, 0.4886 ≤ ADC < 0.6545, 0.6545 ≤ ADC < 0.7750, and ADC ≥ 0.7750; 95% CI, 43.759-62.241, 46.336-53.664, 39.753-46.247, and 27.812-32.188). The OS were 81.0, 61.0, 47.0, and 36.0 months ( < 0.001; 95% CI, 71.356-82.644, 67.630-70.370, 57.031-60.969, and 36.107-43.893). In Cox proportional hazards model, the ADC value was considered to be an independent risk factor affecting PFS and OS of MM (both < 0.001).

CONCLUSIONS

This study supports that ADC in DW-MRI may independently stratify MM patients and better predict their prognosis. The combined use of DW-MRI and other parameters allows more accurate evaluation of MM survival.

TRIAL REGISTRATION

http://www.chictr.org.cn/showproj.aspx?proj=49012, ChiCTR2000029587.

摘要

背景

扩散加权全身磁共振成像(DW-MRI)越来越多地用于评估多发性骨髓瘤(MM)的骨病,但缺乏DW-MRI的定量指标来反映MM的预后。DW-MRI中的表观扩散系数(ADC)值与MM的一些指标之间存在潜在关联,但ADC对MM生存的影响尚需进一步验证。

方法

本研究共纳入381例新诊断的MM患者,分析DW-MRI中ADC值对无进展生存期(PFS)和总生存期(OS)的影响。采用Kaplan-Meier法进行单因素生存分析,Cox比例风险模型进行多因素分析。除ADC值外,还纳入了基因和血清学指标。

结果

在单因素ADC分层中观察到的生存期,中位PFS分别为52.0、45.0、34.0和26.0个月(ADC值单位为10⁻³mm²/s;ADC范围分别为ADC < 0.4886、0.4886≤ADC < 0.6545、0.6545≤ADC < 0.7750和ADC≥0.7750;95%CI,43.759 - 62.241、46.336 - 53.664、39.753 - 46.247和27.812 - 32.188)。OS分别为81.0、61.0、47.0和36.0个月(P < 0.001;95%CI,71.356 - 82.644、67.630 - 70.370、57.031 - 60.969和36.107 - 43.893)。在Cox比例风险模型中,ADC值被认为是影响MM患者PFS和OS的独立危险因素(均P < 0.001)。

结论

本研究支持DW-MRI中的ADC可能独立地对MM患者进行分层并更好地预测其预后。联合使用DW-MRI和其他参数可更准确地评估MM的生存期。

试验注册

http://www.chictr.org.cn/showproj.aspx?proj=49012,ChiCTR2000029587 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/51560b29b183/fonc-12-780078-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/111117648d84/fonc-12-780078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/295b2de7885b/fonc-12-780078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/5fbd3767ca83/fonc-12-780078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/ff15207f581d/fonc-12-780078-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/a537c8818d59/fonc-12-780078-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/51560b29b183/fonc-12-780078-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/111117648d84/fonc-12-780078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/295b2de7885b/fonc-12-780078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/5fbd3767ca83/fonc-12-780078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/ff15207f581d/fonc-12-780078-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/a537c8818d59/fonc-12-780078-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/8931198/51560b29b183/fonc-12-780078-g006.jpg

相似文献

1
The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently.扩散加权全身磁共振成像的表观扩散系数独立影响多发性骨髓瘤的生存期。
Front Oncol. 2022 Mar 4;12:780078. doi: 10.3389/fonc.2022.780078. eCollection 2022.
2
Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.弥散加权磁共振成像的基线骨髓表观扩散系数值:新诊断多发性骨髓瘤患者疾病进展和死亡的潜在独立预测指标
Eur Radiol. 2021 Apr;31(4):1843-1852. doi: 10.1007/s00330-020-07295-6. Epub 2020 Sep 23.
3
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome.单治疗周期后全身定量扩散加权 MRI 是侵袭性非霍奇金淋巴瘤的独立预后因素。
Radiol Imaging Cancer. 2021 Mar 26;3(2):e200061. doi: 10.1148/rycan.2021200061. eCollection 2021 Mar.
4
The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.鼻咽癌治疗前肿瘤表观扩散系数值的预后价值。
BMC Cancer. 2017 Oct 11;17(1):678. doi: 10.1186/s12885-017-3658-x.
5
Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancer.扩散加权磁共振成像获得的表观扩散系数在胰腺癌中的预后相关性
J Magn Reson Imaging. 2015 Dec;42(6):1532-7. doi: 10.1002/jmri.24939. Epub 2015 May 6.
6
Coronal diffusion-weighted magnetic resonance imaging of the kidney: agreement with axial diffusion-weighted magnetic imaging in terms of apparent diffusion coefficient values.肾脏的冠状位扩散加权磁共振成像:在表观扩散系数值方面与轴位扩散加权磁共振成像的一致性。
Chin Med J (Engl). 2015 Feb 20;128(4):499-503. doi: 10.4103/0366-6999.151103.
7
Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.表观扩散系数和肿瘤体积测量有助于对接受贝伐单抗治疗的复发性多形性胶质母细胞瘤患者的无进展生存期进行分层。
Neuroradiol J. 2019 Aug;32(4):241-249. doi: 10.1177/1971400919847184. Epub 2019 May 8.
8
Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.治疗前扩散加权磁共振成像对接受90Y微球放射性栓塞治疗的结直肠癌肝转移患者预后预测的价值
J Cancer Res Clin Oncol. 2017 Aug;143(8):1531-1541. doi: 10.1007/s00432-017-2395-5. Epub 2017 Mar 19.
9
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.贝伐单抗治疗复发性胶质母细胞瘤患者时,增强和未增强肿瘤体积内表观扩散系数的直方图分析。
J Neurooncol. 2014 Aug;119(1):149-58. doi: 10.1007/s11060-014-1464-8. Epub 2014 May 8.
10
Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.基于 MY-RADS 标准的扩散加权全身 MRI(DW-MRI)成像反应对自体干细胞移植后多发性骨髓瘤患者的预测作用,并与流式细胞术 MRD 评估相结合的评估。
Cancer Med. 2021 Sep;10(17):5859-5865. doi: 10.1002/cam4.4136. Epub 2021 Jul 15.

引用本文的文献

1
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.诊断创新:用于多发性骨髓瘤诊断和随访的成像技术进展
J Bone Oncol. 2025 Feb 28;51:100669. doi: 10.1016/j.jbo.2025.100669. eCollection 2025 Apr.
2
Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.用于多发性骨髓瘤定量评估的成像和人工智能(AI)的最新进展。
Am J Nucl Med Mol Imaging. 2024 Aug 25;14(4):208-229. doi: 10.62347/NLLV9295. eCollection 2024.
3
Impact of fat content on lumbar spine DWI performance: A sex-based comparative study.

本文引用的文献

1
Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.使用全身 MRI 的 MY-RADS 总负担评分、ADC 和脂肪分数预测多发性骨髓瘤的早期治疗反应:贫血对预测性能的影响。
AJR Am J Roentgenol. 2022 Feb;218(2):310-319. doi: 10.2214/AJR.21.26534. Epub 2021 Sep 15.
2
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.多发性骨髓瘤及前体疾病的流行病学、遗传学和治疗。
Int J Cancer. 2021 Dec 15;149(12):1980-1996. doi: 10.1002/ijc.33762. Epub 2021 Aug 30.
3
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute.
脂肪含量对腰椎扩散加权成像(DWI)表现的影响:一项基于性别的比较研究。
Eur J Radiol Open. 2024 Aug 31;13:100597. doi: 10.1016/j.ejro.2024.100597. eCollection 2024 Dec.
4
3D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients  with Multiple Myeloma using Whole-body MRI.基于 3D CNN 的深度学习模型对多发性骨髓瘤患者进行全身 MRI 解释预后预测。
J Med Syst. 2024 Mar 8;48(1):30. doi: 10.1007/s10916-024-02040-8.
5
Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI.功能成像在多发性骨髓瘤治疗反应评估中的应用:PET-CT与MRI的作用
J Pers Med. 2022 Nov 10;12(11):1885. doi: 10.3390/jpm12111885.
乌干达癌症研究所多发性骨髓瘤患者的特征和结局。
Afr Health Sci. 2021 Mar;21(1):67-74. doi: 10.4314/ahs.v21i1.11.
4
Conductivity Tensor Imaging of the Human Brain Using Water Mapping Techniques.利用水成像技术对人脑进行电导率张量成像
Front Neurosci. 2021 Jul 30;15:694645. doi: 10.3389/fnins.2021.694645. eCollection 2021.
5
Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival.轻链型多发性骨髓瘤亚组:肾功能受损与生存时间缩短相关。
Lab Med. 2022 Mar 7;53(2):145-148. doi: 10.1093/labmed/lmab054.
6
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14). Venetoclax 联合达雷妥尤单抗和地塞米松,加或不加硼替佐米,治疗伴有和不伴有 t(11;14)的复发/难治性多发性骨髓瘤的 I 期研究。
J Clin Oncol. 2021 Nov 10;39(32):3602-3612. doi: 10.1200/JCO.21.00443. Epub 2021 Aug 13.
7
Whole-tumor histogram analysis of apparent diffusion coefficient for differentiating adenosquamous carcinoma and adenocarcinoma from squamous cell carcinoma in patients with cervical cancer.全肿瘤直方图分析表观扩散系数鉴别宫颈癌中鳞癌、腺鳞癌与腺癌。
Acta Radiol. 2022 Oct;63(10):1415-1424. doi: 10.1177/02841851211035915. Epub 2021 Aug 12.
8
Imaging in multiple myeloma: Computed tomography or magnetic resonance imaging?多发性骨髓瘤的影像学检查:计算机断层扫描还是磁共振成像?
World J Radiol. 2021 Jul 28;13(7):223-226. doi: 10.4329/wjr.v13.i7.223.
9
A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.循环微RNA的分子特征可预测多发性骨髓瘤中的溶骨性骨病。
Cancers (Basel). 2021 Jul 31;13(15):3877. doi: 10.3390/cancers13153877.
10
Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.用于评估多发性骨髓瘤患者肿瘤负荷的定量全身磁共振成像:与预后生物标志物的相关性
Quant Imaging Med Surg. 2021 Aug;11(8):3767-3780. doi: 10.21037/qims-20-1361.